Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aiko Maejima

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|May 2, 2024
Clinical characteristics and survival outcomes of elderly patients with de novo metastatic germ cell tumorsTakahiro Kirisawa, Tomoya Okuno, Hiroki Hagimoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 19, 2025
Outcomes of Patients With International Germ Cell Cancer Collaborative Group Good Prognosis Metastatic Seminoma Undergoing De-Escalation Chemotherapy: A Single-Center Retrospective StudyTakahiro Kirisawa, Hiroki Hagimoto, Tomoya Okuno, et al.
International Journal of Clinical Oncology|May 28, 2025
The prognostic factors and treatment patterns of the first recurrence of retroperitoneal liposarcomaYoshiyuki Matsui, Shintaro Iwata, Konosuke Moritani, et al.
Japanese Journal of Clinical Oncology|March 29, 2023
Predictive value of peripheral blood markers in soft tissue sarcoma patients treated with eribulinShin Ishihara, Koichi Ogura, Aiko Maejima, et al.
Oncology|February 4, 2025
Treatment and Reasons for Choosing Treatment in Breast Cancer Patients Who Underwent Next-Generation Sequencing TestRumi Nishimura, Kazuki Sudo, Rui Kitadai, et al.
Breast Cancer (Tokyo, Japan)|July 28, 2025
Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancerMai Hoshino, Tatsunori Shimoi, Taro Yamanaka, et al.
Cancer Medicine|August 5, 2020
Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancerKeisuke Tsuchida, Koji Inaba, Tairo Kashihara, et al.
Head & Neck|May 20, 2025
Efficacy of Eribulin Monotherapy in Patients With Unresectable and/or Metastatic Adenoid Cystic Carcinoma Receiving Platinum-Based TherapyTomomi Sanomachi, Tatsunori Shimoi, Yuki Kojima, et al.
Breast Cancer Research and Treatment|June 22, 2026
Clinical implications of discordance in HER2 reassessment from HercepTest to 4B5 in metastatic breast cancerYuhei Yamaguchi, Mai Hoshino, Tatsunori Shimoi, et al.
Anticancer Research|April 27, 2024
Predicting Trabectedin Efficacy in Soft Tissue Sarcoma: Inflammatory Biomarker AnalysisToru Imai, Yuki Kojima, Tatsunori Shimoi, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Urology : Official Journal of the Japanese Urological Association|May 2, 2024
Clinical characteristics and survival outcomes of elderly patients with de novo metastatic germ cell tumorsTakahiro Kirisawa, Tomoya Okuno, Hiroki Hagimoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 19, 2025
Outcomes of Patients With International Germ Cell Cancer Collaborative Group Good Prognosis Metastatic Seminoma Undergoing De-Escalation Chemotherapy: A Single-Center Retrospective StudyTakahiro Kirisawa, Hiroki Hagimoto, Tomoya Okuno, et al.
International Journal of Clinical Oncology|May 28, 2025
The prognostic factors and treatment patterns of the first recurrence of retroperitoneal liposarcomaYoshiyuki Matsui, Shintaro Iwata, Konosuke Moritani, et al.
Japanese Journal of Clinical Oncology|March 29, 2023
Predictive value of peripheral blood markers in soft tissue sarcoma patients treated with eribulinShin Ishihara, Koichi Ogura, Aiko Maejima, et al.
Oncology|February 4, 2025
Treatment and Reasons for Choosing Treatment in Breast Cancer Patients Who Underwent Next-Generation Sequencing TestRumi Nishimura, Kazuki Sudo, Rui Kitadai, et al.
Breast Cancer (Tokyo, Japan)|July 28, 2025
Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancerMai Hoshino, Tatsunori Shimoi, Taro Yamanaka, et al.
Cancer Medicine|August 5, 2020
Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancerKeisuke Tsuchida, Koji Inaba, Tairo Kashihara, et al.
Head & Neck|May 20, 2025
Efficacy of Eribulin Monotherapy in Patients With Unresectable and/or Metastatic Adenoid Cystic Carcinoma Receiving Platinum-Based TherapyTomomi Sanomachi, Tatsunori Shimoi, Yuki Kojima, et al.
Breast Cancer Research and Treatment|June 22, 2026
Clinical implications of discordance in HER2 reassessment from HercepTest to 4B5 in metastatic breast cancerYuhei Yamaguchi, Mai Hoshino, Tatsunori Shimoi, et al.
Anticancer Research|April 27, 2024
Predicting Trabectedin Efficacy in Soft Tissue Sarcoma: Inflammatory Biomarker AnalysisToru Imai, Yuki Kojima, Tatsunori Shimoi, et al.
Pageof 3